Coliseo

Head-to-Head Startup Ranking & Discovery

E

Eris Biotech

Bio · US · Early-stage

erisbio.com ↗

We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.

Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →